Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis

BACKGROUND: Infliximab (IFX) has been widely used in ulcerative colitis (UC) patients. However, the subsequent effective treatment of IFX non-response in UC patients remains a challenge. This study aims to predict potential therapeutic targets for non-responders by performing a bioinformatic analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Xue, Zhang, Zhe, Liu, Xia, Geng, Li, Zhang, Muhan, Feng, Baisui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198282/
https://www.ncbi.nlm.nih.gov/pubmed/37215377
http://dx.doi.org/10.2147/JIR.S409290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198282/
https://www.ncbi.nlm.nih.gov/pubmed/37215377
http://dx.doi.org/10.2147/JIR.S409290

Ejemplares similares